| scholarly article | Q13442814 |
| P2093 | author name string | Chao Liu | |
| Ling Zhang | |||
| Xuan Wang | |||
| Jia Wei Zheng | |||
| Yan An Wang | |||
| Hai Wei Wu | |||
| P2860 | cites work | Interventions for infantile haemangiomas of the skin. | Q53280418 |
| Evaluation of the efficacy and safety of propranolol, timolol maleate, and the combination of the two, in the treatment of superficial infantile haemangiomas | Q56976475 | ||
| Propranolol induces hemangioma endothelial cell apoptosis via a p53‑BAX mediated pathway. | Q64931736 | ||
| Propranolol for infantile haemangiomas: certain chances, potential risks | Q86515034 | ||
| RCT of timolol maleate gel for superficial infantile hemangiomas in 5- to 24-week-olds | Q86728107 | ||
| Propranolol inhibits proliferation and invasion of hemangioma-derived endothelial cells by suppressing the DLL4/Notch1/Akt pathway | Q91063758 | ||
| Hemangiomas of infancy and childhood | Q95811658 | ||
| Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action | Q33574011 | ||
| Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma | Q33835368 | ||
| Propranolol targets the contractility of infantile haemangioma-derived pericytes. | Q34323894 | ||
| Early growth of infantile hemangiomas: what parents' photographs tell us. | Q34349260 | ||
| A randomized, controlled trial of oral propranolol in infantile hemangioma. | Q34668015 | ||
| Biology of infantile hemangioma | Q34867993 | ||
| Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases | Q36122560 | ||
| Pathogenesis of infantile haemangioma. | Q37001304 | ||
| Treatment of superficial infantile hemangiomas with timolol: Evaluation of short-term efficacy and safety in infants | Q37207304 | ||
| Update on vascular tumors of infancy | Q37770044 | ||
| Infantile hemangioma-mechanism(s) of drug action on a vascular tumor. | Q37974217 | ||
| Topical propranolol for treatment of superficial infantile hemangiomas | Q38003752 | ||
| Propranolol and infantile hemangiomas four years later: a systematic review | Q38081161 | ||
| Propranolol and central nervous system function: potential implications for paediatric patients with infantile haemangiomas | Q38245087 | ||
| Review of topical beta blockers as treatment for infantile hemangiomas | Q38412308 | ||
| Infantile Hemangiomas: Pathogenesis and Review of Propranolol Use. | Q38761686 | ||
| Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway | Q38904889 | ||
| Topical Timolol Maleate Treatment of Infantile Hemangiomas | Q38928366 | ||
| Safety of Oral Propranolol for the Treatment of Infantile Hemangioma: A Systematic Review | Q38968660 | ||
| Infantile haemangioma | Q39089425 | ||
| Expression of β-Adrenergic Receptor Subtypes in Proliferative, Involuted, and Propranolol-Responsive Infantile Hemangiomas | Q39294736 | ||
| Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey. | Q40424734 | ||
| Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study | Q44360789 | ||
| Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study | Q44983135 | ||
| Propranolol for severe hemangiomas of infancy. | Q46542573 | ||
| Growth characteristics of infantile hemangiomas: implications for management | Q46787208 | ||
| Propranolol treatment of infantile hemangioma (IH) is not associated with developmental risk or growth impairment at age 4 years | Q47873390 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 605 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Frontiers in Oncology | Q26839986 |
| P1476 | title | Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas | |
| P478 | volume | 8 |
| Q92425256 | Failed Treatment of Classic Kaposi's Sarcoma with Topical Timolol: Case Report and Review of the Literature |
| Q92431192 | Lycium barbarum polysaccharide induced apoptosis and inhibited proliferation in infantile hemangioma endothelial cells via down-regulation of PI3K/AKT signaling pathway |
| Q92593924 | Progress in the treatment of infantile hemangioma |
Search more.